Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Tracon Pharmaceuticals Inc (TCON)

Tracon Pharmaceuticals Inc (TCON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 4,286
  • Shares Outstanding, K 2,679
  • Annual Sales, $ 12,050 K
  • Annual Income, $ -3,590 K
  • 60-Month Beta 1.25
  • Price/Sales 0.32
  • Price/Cash Flow 0.84
  • Price/Book N/A
Trade TCON with:
  • Price/Earnings ttm 0.41
  • Earnings Per Share ttm 3.47
  • Most Recent Earnings $-1.33 on 05/14/24
  • Next Earnings Date 08/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -1.00
  • Number of Estimates 1
  • High Estimate -1.00
  • Low Estimate -1.00
  • Prior Year -1.20
  • Growth Rate Est. (year over year) +16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6600 +113.64%
on 06/12/24
1.7700 -20.34%
on 06/27/24
+0.1300 (+10.16%)
since 05/31/24
3-Month
0.6600 +113.64%
on 06/12/24
8.5400 -83.49%
on 04/02/24
-6.8160 (-82.86%)
since 04/01/24
52-Week
0.6600 +113.64%
on 06/12/24
14.7460 -90.44%
on 03/13/24
-4.4100 (-75.77%)
since 06/30/23

Most Recent Stories

More News
Tracon: Q1 Earnings Snapshot

Tracon: Q1 Earnings Snapshot

TCON : 1.4100 (-11.88%)
Tracon: Q4 Earnings Snapshot

Tracon: Q4 Earnings Snapshot

TCON : 1.4100 (-11.88%)
Tracon: Q3 Earnings Snapshot

Tracon: Q3 Earnings Snapshot

TCON : 1.4100 (-11.88%)
Tracon: Q2 Earnings Snapshot

Tracon: Q2 Earnings Snapshot

TCON : 1.4100 (-11.88%)
Tracon: Q1 Earnings Snapshot

Tracon: Q1 Earnings Snapshot

TCON : 1.4100 (-11.88%)
Tracon: Q4 Earnings Snapshot

Tracon: Q4 Earnings Snapshot

TCON : 1.4100 (-11.88%)
Tracon: Q3 Earnings Snapshot

Tracon: Q3 Earnings Snapshot

TCON : 1.4100 (-11.88%)
US FDA Approval of IND for CTLA-4 Antibody YH001 for the Treatment of Front-line Sarcoma Patients in Combination with Envafolimab

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen") and TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), today jointly announced that the U.S. Food and Drug Administration (FDA) has approved the...

TCON : 1.4100 (-11.88%)
TRACON Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

SAN DIEGO, Aug. 10, 2022 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...

TCON : 1.4100 (-11.88%)
TRACON Pharmaceuticals Announces Results of Independent Data Monitoring Committee Review of Safety Data from ENVASARC Pivotal Trial

Trial to Continue as Planned...

TCON : 1.4100 (-11.88%)

Business Summary

TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California....

See More

Key Turning Points

3rd Resistance Point 2.7833
2nd Resistance Point 2.2467
1st Resistance Point 1.9233
Last Price 1.4100
1st Support Level 1.0633
2nd Support Level 0.5267
3rd Support Level 0.2033

See More

52-Week High 14.7460
Fibonacci 61.8% 9.3651
Fibonacci 50% 7.7030
Fibonacci 38.2% 6.0409
Last Price 1.4100
52-Week Low 0.6600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar